I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Atezolizumab, vemurafenib, and cobimetinib as first-line tr..:
Gutzmer, Ralf
;
Stroyakovskiy, Daniil
;
Gogas, Helen
...
The Lancet. 395 (2020) 10240 - p. 1835-1844 , 2020
Link:
https://doi.org/10.1016/s0140-6736(20)30934-x
RT Journal T1
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_s0140-6736(20)30934-x&Exemplar=1&LAN=DE A1 Gutzmer, Ralf A1 Stroyakovskiy, Daniil A1 Gogas, Helen A1 Robert, Caroline A1 Lewis, Karl A1 Protsenko, Svetlana A1 Pereira, Rodrigo P A1 Eigentler, Thomas A1 Rutkowski, Piotr A1 Demidov, Lev A1 Manikhas, Georgy Moiseevich A1 Yan, Yibing A1 Huang, Kuan-Chieh A1 Uyei, Anne A1 McNally, Virginia A1 McArthur, Grant A A1 Ascierto, Paolo A PB Elsevier BV YR 2020 SN 0140-6736 JF The Lancet VO 395 IS 10240 SP 1835 OP 1844 LK http://dx.doi.org/https://doi.org/10.1016/s0140-6736(20)30934-x DO https://doi.org/10.1016/s0140-6736(20)30934-x SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)